Aspira Pathlab & Diagnostics Ltd (540788) — FY26 Annual Report | 31 August 2026

Aspira Pathlab & Diagnostics Limited submitted its Annual Report for FY 2025-26 on August 31, 2026, detailing governance, AGM notice, financial statements, and shareholder matters. The report covers board appointments, including the redesignation of Nikunj Mange as Managing Director effective August 12, 2026, and Vaibhav Odhekar as Executive Director. It outlines related party transactions with Yashraj Research Foundation, capped at Rs. 5 crores, and shareholder approval requirements. The company reported revenue of Rs. 2,498.20 lakhs, profit of Rs. 5.13 lakhs, and no dividend recommendation. Governance disclosures include board composition, risk management, and compliance with SEBI regulations. The filing includes audit reports, director remuneration details, and procedural instructions for e-voting and AGM participation via video conferencing.